focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Sep 2020 10:57

RNS Number : 3157Z
Premier Veterinary Group PLC
17 September 2020
 

17 September 2020 

 

Premier Veterinary Group PLC

 

("PVG", the "Company" or the "Group")

 

Director/ PDMR dealing

 

 

Premier Veterinary Group PLC (LSE: PVG), on 17 September 2020, received notification of the following dealings in ordinary shares of 10p each in the capital of the Company.

 

Andrew Paull, the Company's Chief Financial Officer, purchased 55,000 shares on 16 September 2020 for a price of 34.97 pence per share.

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

For further information, please contact:

 

Premier Veterinary Group plc

Dominic Tonner, Chief Executive Officer

Andy Paull, Chief Financial Officer

 

Tel: +44 (0)117 970 4130

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Andrew Paull

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Premier Veterinary Group plc

b)

 

LEI

 

 

2138009B5L8VQUZ9A719

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10p each

Identification code

GB00BSZLMS59

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Purchase of shares

36.00p

55,000

d)

 

Aggregated information

Purchase of shares

- Aggregated volume

55,000

- Price

£19,800

e)

 

Date of the transaction

 

16/09/2020

f)

 

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFEAARIDLII
Date   Source Headline
17th May 201010:17 amRNSForm 8.5 (EPT/NON-RI)
14th May 201011:16 amRNSForm 8.5 (EPT/RI)
14th May 20109:36 amRNSForm 8.5 (EPT/NON-RI)
12th May 201010:39 amRNSForm 8.5 (EPT/RI)
12th May 20109:49 amRNSForm 8.5 (EPT/NON-RI)
11th May 20108:41 amRNSForm 8.5 (EPT/NON-RI)
10th May 20104:19 pmRNSForm 8.3 - [Ark Therapeutics Grp]
10th May 201010:41 amRNSForm 8.5 (EPT/NON-RI)
7th May 20102:37 pmRNSForm 8.3 - Ark Therapeutics Grp
7th May 201010:03 amRNSForm 8.5 (EPT/RI)
7th May 201010:01 amRNSForm 8.5 (EPT/NON-RI)
6th May 201012:24 pmRNSForm 8.3 - Ark Therapeutics Group PLC
6th May 20109:49 amRNSForm 8.5 (EPT/NON-RI)
5th May 201011:48 amRNSForm 8.3 - (Ark Therapeutics)
5th May 20107:00 amRNSStrategic Review
4th May 20101:54 pmRNSForm 8 (OPD) Ark Therapeutics Group
4th May 20101:36 pmRNSForm 8.5 (EPT/NON-RI)
30th Apr 20101:43 pmRNSForm 8.3 - Ark Therapeutics Group PLC
30th Apr 201012:05 pmRNSTotal Voting Rights
30th Apr 201012:03 pmRNSDirector/PDMR Shareholding
30th Apr 201011:55 amRNSForm 8 (DD) - Ark Therapeutics Group PLC
30th Apr 201010:49 amRNSForm 8.5 (EPT/RI)
29th Apr 201011:11 amRNSForm 8.5 (EPT/NON-RI)
29th Apr 201011:04 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 20102:44 pmRNSForm 8.3 - Ark Therapeutics Group plc
28th Apr 201010:31 amRNSForm 8.5 (EPT/NON-RI)
27th Apr 201011:40 amRNSForm 8.5 (EPT/RI)
26th Apr 20102:53 pmRNSForm 8.3 - ARK THERAPEUTICS
26th Apr 201012:43 pmRNSForm 8.3 - Ark Therapeutics Group plc
26th Apr 201011:30 amRNSForm 8.5 (EPT/RI)
26th Apr 20109:42 amRNSForm 8.5 (EPT/NON-RI)
23rd Apr 201011:43 amRNSForm 8.3 - ARK THERAPEUTICS
23rd Apr 201011:36 amRNSForm 8.5 (EPT/RI)
23rd Apr 201010:16 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 201011:33 amRNSForm 8.3 - ARK THERAPEUTICS
22nd Apr 201011:03 amRNSForm 8.3 - Ark Therapeutics Group Plc
22nd Apr 20109:48 amRNSForm 8.5 (EPT/RI)
21st Apr 20101:47 pmRNSForm 8.3 - ARK THERAPEUTICS
21st Apr 201012:05 pmRNSResult of AGM
21st Apr 20109:11 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20103:56 pmRNSForm 8.3 - Ark Therapeutics Group Plc
20th Apr 201012:49 pmBUSForm 8.3 - Ark Therapeutics Group plc
20th Apr 201011:37 amRNSForm 8.5 (EPT/RI)
20th Apr 20109:48 amRNSForm 8.3 - Ark Therapeutics Plc
20th Apr 20108:53 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20102:44 pmRNSForm 8.3 - Ark Therapeutics Group plc
19th Apr 201011:31 amRNSForm 8.5 (EPT/NON-RI)
19th Apr 20107:00 amRNSResearch Update
16th Apr 201010:32 amRNSEPT Disclosure
16th Apr 20109:32 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.